JPH10512956A - 免疫測定法の改良 - Google Patents

免疫測定法の改良

Info

Publication number: JPH10512956A
Authority: JP; Japan
Prior art keywords: capture; solid phase; signal; label; component
Prior art date: 1995-01-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP8522723A

Other languages

English (en)

Japanese (ja)

Inventor

ジュリアンスチュアートダンカン，リチャード

Original Assignee

ミュレクスダイアノスティクスコーポレイション

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-01-25

Filing date

1996-01-25

Publication date

1998-12-08

1995-01-25 Priority claimed from GBGB9501416.3A external-priority patent/GB9501416D0/en

1995-01-25 Priority claimed from GBGB9501415.5A external-priority patent/GB9501415D0/en

1995-01-27 Priority claimed from GBGB9501622.6A external-priority patent/GB9501622D0/en

1996-01-25 Application filed by ミュレクスダイアノスティクスコーポレイション filed Critical ミュレクスダイアノスティクスコーポレイション

1998-12-08 Publication of JPH10512956A publication Critical patent/JPH10512956A/ja

Status Pending legal-status Critical Current

Links

238000003018 immunoassay Methods 0.000 title claims abstract description 61
239000007790 solid phase Substances 0.000 claims abstract description 114
238000003556 assay Methods 0.000 claims abstract description 62
238000000034 method Methods 0.000 claims abstract description 54
230000009870 specific binding Effects 0.000 claims abstract description 44
239000000126 substance Substances 0.000 claims abstract description 44
239000012491 analyte Substances 0.000 claims abstract description 37
238000005259 measurement Methods 0.000 claims abstract description 37
238000012360 testing method Methods 0.000 claims abstract description 21
230000027455 binding Effects 0.000 claims description 24
102000004190 Enzymes Human genes 0.000 claims description 23
108090000790 Enzymes Proteins 0.000 claims description 23
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 20
238000002372 labelling Methods 0.000 claims description 15
230000008859 change Effects 0.000 claims description 11
229960002685 biotin Drugs 0.000 claims description 10
235000020958 biotin Nutrition 0.000 claims description 10
239000011616 biotin Substances 0.000 claims description 10
238000001514 detection method Methods 0.000 claims description 10
239000007850 fluorescent dye Substances 0.000 claims description 8
230000003100 immobilizing effect Effects 0.000 claims description 3
238000002360 preparation method Methods 0.000 claims 1
238000000576 coating method Methods 0.000 abstract description 23
239000011248 coating agent Substances 0.000 abstract description 18
239000000427 antigen Substances 0.000 description 33
102000036639 antigens Human genes 0.000 description 33
108091007433 antigens Proteins 0.000 description 33
239000003446 ligand Substances 0.000 description 19
239000003153 chemical reaction reagent Substances 0.000 description 16
239000000243 solution Substances 0.000 description 15
239000011324 bead Substances 0.000 description 13
238000004519 manufacturing process Methods 0.000 description 11
238000006243 chemical reaction Methods 0.000 description 10
239000000523 sample Substances 0.000 description 10
239000002245 particle Substances 0.000 description 9
235000018102 proteins Nutrition 0.000 description 9
102000004169 proteins and genes Human genes 0.000 description 9
108090000623 proteins and genes Proteins 0.000 description 9
241000894007 species Species 0.000 description 9
239000000758 substrate Substances 0.000 description 9
108060003951 Immunoglobulin Proteins 0.000 description 8
102000018358 immunoglobulin Human genes 0.000 description 8
239000000203 mixture Substances 0.000 description 8
230000002285 radioactive effect Effects 0.000 description 8
241000713772 Human immunodeficiency virus 1 Species 0.000 description 7
238000000691 measurement method Methods 0.000 description 7
239000012071 phase Substances 0.000 description 7
239000008280 blood Substances 0.000 description 6
238000005406 washing Methods 0.000 description 6
108010090804 Streptavidin Proteins 0.000 description 5
210000004369 blood Anatomy 0.000 description 5
108090001008 Avidin Proteins 0.000 description 4
108010001336 Horseradish Peroxidase Proteins 0.000 description 4
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 4
239000000872 buffer Substances 0.000 description 4
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 4
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
239000012528 membrane Substances 0.000 description 4
230000003287 optical effect Effects 0.000 description 4
QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 4
239000007787 solid Substances 0.000 description 4
-1 washes Substances 0.000 description 4
208000031886 HIV Infections Diseases 0.000 description 3
241000713340 Human immunodeficiency virus 2 Species 0.000 description 3
238000002835 absorbance Methods 0.000 description 3
239000000556 agonist Substances 0.000 description 3
239000005557 antagonist Substances 0.000 description 3
230000008901 benefit Effects 0.000 description 3
210000004027 cell Anatomy 0.000 description 3
230000007547 defect Effects 0.000 description 3
238000011534 incubation Methods 0.000 description 3
239000000463 material Substances 0.000 description 3
102000013415 peroxidase activity proteins Human genes 0.000 description 3
108040007629 peroxidase activity proteins Proteins 0.000 description 3
238000012216 screening Methods 0.000 description 3
108010088751 Albumins Proteins 0.000 description 2
102000009027 Albumins Human genes 0.000 description 2
108010078791 Carrier Proteins Proteins 0.000 description 2
102000014914 Carrier Proteins Human genes 0.000 description 2
108090000695 Cytokines Proteins 0.000 description 2
102000004127 Cytokines Human genes 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
102000051325 Glucagon Human genes 0.000 description 2
108060003199 Glucagon Proteins 0.000 description 2
241000725303 Human immunodeficiency virus Species 0.000 description 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
102000004877 Insulin Human genes 0.000 description 2
108090001061 Insulin Proteins 0.000 description 2
239000000020 Nitrocellulose Substances 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
239000004952 Polyamide Substances 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
101710120037 Toxin CcdB Proteins 0.000 description 2
101800000385 Transmembrane protein Proteins 0.000 description 2
239000002253 acid Substances 0.000 description 2
230000001800 adrenalinergic effect Effects 0.000 description 2
238000004220 aggregation Methods 0.000 description 2
230000002776 aggregation Effects 0.000 description 2
229940024606 amino acid Drugs 0.000 description 2
150000001413 amino acids Chemical class 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
239000010839 body fluid Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
230000001713 cholinergic effect Effects 0.000 description 2
238000004737 colorimetric analysis Methods 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
229960003638 dopamine Drugs 0.000 description 2
230000000694 effects Effects 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 2
229960004666 glucagon Drugs 0.000 description 2
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
239000010931 gold Substances 0.000 description 2
229910052737 gold Inorganic materials 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
239000005556 hormone Substances 0.000 description 2
229940125396 insulin Drugs 0.000 description 2
239000012948 isocyanate Substances 0.000 description 2
239000007788 liquid Substances 0.000 description 2
229920005615 natural polymer Polymers 0.000 description 2
229920001220 nitrocellulos Polymers 0.000 description 2
229920002647 polyamide Polymers 0.000 description 2
229920000915 polyvinyl chloride Polymers 0.000 description 2
239000004800 polyvinyl chloride Substances 0.000 description 2
230000008569 process Effects 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
238000000275 quality assurance Methods 0.000 description 2
230000006798 recombination Effects 0.000 description 2
238000005215 recombination Methods 0.000 description 2
229940076279 serotonin Drugs 0.000 description 2
230000005062 synaptic transmission Effects 0.000 description 2
229920001059 synthetic polymer Polymers 0.000 description 2
238000010200 validation analysis Methods 0.000 description 2
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
HBEYDAQVMXPRDT-UHFFFAOYSA-N 2-aminoacetic acid;boric acid Chemical compound OB(O)O.NCC(O)=O HBEYDAQVMXPRDT-UHFFFAOYSA-N 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
241000736839 Chara Species 0.000 description 1
102000006395 Globulins Human genes 0.000 description 1
108010044091 Globulins Proteins 0.000 description 1
239000007995 HEPES buffer Substances 0.000 description 1
241000282412 Homo Species 0.000 description 1
241001424413 Lucia Species 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
239000002033 PVDF binder Substances 0.000 description 1
241001494479 Pecora Species 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
241000473945 Theria <moth genus> Species 0.000 description 1
108010046334 Urease Proteins 0.000 description 1
238000007818 agglutination assay Methods 0.000 description 1
102000005936 beta-Galactosidase Human genes 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
239000002981 blocking agent Substances 0.000 description 1
239000010836 blood and blood product Substances 0.000 description 1
210000000601 blood cell Anatomy 0.000 description 1
230000003139 buffering effect Effects 0.000 description 1
239000011545 carbonate/bicarbonate buffer Substances 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
210000000078 claw Anatomy 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
238000004040 coloring Methods 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000010276 construction Methods 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
238000012937 correction Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
239000003599 detergent Substances 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
239000012470 diluted sample Substances 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
238000001035 drying Methods 0.000 description 1
239000000975 dye Substances 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
238000011049 filling Methods 0.000 description 1
239000012530 fluid Substances 0.000 description 1
ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
239000000499 gel Substances 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
239000003365 glass fiber Substances 0.000 description 1
208000002672 hepatitis B Diseases 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
238000005304 joining Methods 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
239000002184 metal Substances 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
238000002156 mixing Methods 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
239000006174 pH buffer Substances 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
244000052769 pathogen Species 0.000 description 1
238000000053 physical method Methods 0.000 description 1
239000000049 pigment Substances 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
229920002981 polyvinylidene fluoride Polymers 0.000 description 1
238000000159 protein binding assay Methods 0.000 description 1
238000003908 quality control method Methods 0.000 description 1
230000005855 radiation Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
239000012089 stop solution Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000000052 vinegar Substances 0.000 description 1
235000021419 vinegar Nutrition 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Analytical Chemistry (AREA)
Cell Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Food Science & Technology (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

JP8522723A 1995-01-25 1996-01-25 免疫測定法の改良 Pending JPH10512956A (ja)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
GB9501416.3		1995-01-25
GBGB9501416.3A GB9501416D0 (en)	1995-01-25	1995-01-25	Immunoassay
GB9501415.5		1995-01-25
GBGB9501415.5A GB9501415D0 (en)	1995-01-25	1995-01-25	Immunoassay
GBGB9501622.6A GB9501622D0 (en)	1995-01-27	1995-01-27	Immunoassay
GB9501622.6		1995-01-27
PCT/GB1996/000152 WO1996023228A1 (fr)	1995-01-25	1996-01-25	Amelioration d'immuno-essais

Publications (1)

Publication Number	Publication Date
JPH10512956A true JPH10512956A (ja)	1998-12-08

Family

ID=27267557

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP8522723A Pending JPH10512956A (ja)	1995-01-25	1996-01-25	免疫測定法の改良

Country Status (5)

Country	Link
EP (1)	EP0805982A1 (fr)
JP (1)	JPH10512956A (fr)
AU (1)	AU4456396A (fr)
CA (1)	CA2211322A1 (fr)
WO (1)	WO1996023228A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2005526950A (ja) *	2001-07-27	2005-09-08	ロンザ・グループ・アーゲー	抗体発現細胞を選択する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4606855A (en) *	1982-07-26	1986-08-19	Mex Research Associates C/O Leon Reimer	Monoclonal antibody to digoxin
GB9211980D0 (en) *	1992-06-05	1992-07-15	Int Murex Tech Corp	Immunoassay method

1996
- 1996-01-25 EP EP96900665A patent/EP0805982A1/fr not_active Ceased
- 1996-01-25 AU AU44563/96A patent/AU4456396A/en not_active Abandoned
- 1996-01-25 JP JP8522723A patent/JPH10512956A/ja active Pending
- 1996-01-25 CA CA 2211322 patent/CA2211322A1/fr not_active Abandoned
- 1996-01-25 WO PCT/GB1996/000152 patent/WO1996023228A1/fr not_active Ceased

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2005526950A (ja) *	2001-07-27	2005-09-08	ロンザ・グループ・アーゲー	抗体発現細胞を選択する方法

Also Published As

Publication number	Publication date
EP0805982A1 (fr)	1997-11-12
CA2211322A1 (fr)	1996-08-01
AU4456396A (en)	1996-08-14
WO1996023228A1 (fr)	1996-08-01

Publication	Publication Date	Title
AU689174B2 (en)	1998-03-26	Sensor device for sandwich assay
US5616467A (en)	1997-04-01	Method and kit for analyte detection employing gold-sol bound antibodies
US5631170A (en)	1997-05-20	Method for improving measurement precision in evanescent wave optical biosensor assays
JPH08240591A (ja)	1996-09-17	免疫クロマトグラフィー用試験片上での被検物質の定量法
JP2024074809A (ja)	2024-05-31	側方流動アッセイのシグナルを増幅させるシステム、装置および方法
US20200333337A1 (en)	2020-10-22	Method for re-using test probe and reagents in an immunoassay
EP0564494B1 (fr)	1994-12-14	Procede d'essai et kit reactif associe
US8569073B2 (en)	2013-10-29	Test element having combined control and calibration zone
CA2183204A1 (fr)	1997-02-17	Biocapteur optique operant en phase solide a base de streptavidine et de biotine
JPH06502720A (ja)	1994-03-24	分析方法
JPH10512956A (ja)	1998-12-08	免疫測定法の改良
JP2000258418A (ja)	2000-09-22	免疫クロマトグラフィーを用いた測定方法およびそれに用いる検体分析用具
US20050074902A1 (en)	2005-04-07	Method for obtaining a unique calibration system applied to multi-parametric doses of biological samples, immunologicaLreagent prepared for that purpose, and dosage method
JP2000241431A (ja)	2000-09-08	免疫グロブリンａ−フィブロネクチン複合体の免疫学的測定試薬および測定法
JP2009257764A (ja)	2009-11-05	リポソーム複合体、リポソームアレイ、および被検物質を検出する方法
JP3768165B2 (ja)	2006-04-19	抗カルパスタチン抗体の測定法及び測定キット
JPS58206966A (ja)	1983-12-02	同時較正不均質イムノアツセイ
HK1001234A (en)	1998-06-05	Test method and reagent kit therefor
HK1001234B (en)	1998-06-05	Test method and reagent kit therefor
HK1001235B (en)	1998-06-05	Test method and reagent kit therefor
HK1001235A (en)	1998-06-05	Test method and reagent kit therefor
JPH02201265A (ja)	1990-08-09	酵素定量ウィッキングアッセイ

JPH10512956A - 免疫測定法の改良 - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (7)

Publications (1)

Family

ID=27267557

Family Applications (1)

Country Status (5)

Cited By (1)

Family Cites Families (2)

Cited By (1)

Also Published As

Similar Documents